Accelerating Large Molecule Drug Development

At. one stop along Pharma's Almanac's Road to 50 States trip Ryan Dorfman, Vice President of Operations at Haematologic Technologies, talks to Nigel about how the company uses its close relationship with their clients to provide high-quality data in time.

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Haematologic Technologies

Nearly three decades ago, HT began operations as a research reagents company. With deep expertise in coagulation and hemostasis, we provided highly purified plasma proteins and antibodies to research labs around the world. Soon, biopharma customers began utilizing HT’s analytical and purification services around both native and recombinant therapeutics.  Today, HT is well-known for our deep protein chemistry expertise, integrated large molecule analytical platforms, our preeminent knowledge of the chemistry of blood, and our philosophy of “Science with a Sense of Urgency”. Our services and products bridge both Product Development and Clinical domains from discovery to commercial release, and HT has grown into a leading provider of expertise in large molecule analytical chemistry from plasma therapeutics to mAb’s to gene therapies. HT is truly a large molecule CRO unlike any other.